-

Celiac Disease Foundation, Celiac Cruise Announce Partnership to Enrich, Expand Travel Experiences for Celiac Disease Community

LOS ANGELES & ORLANDO, Fla.--(BUSINESS WIRE)--The Celiac Disease Foundation, a leading global patient advocacy organization committed to accelerating diagnosis, treatments, and a cure for celiac disease, and Celiac Cruise, a pioneer in gluten-free travel, today are pleased to announce an innovative partnership to offer safe and delicious gluten-free travel experiences, provide educational opportunities, and foster philanthropy within the celiac disease community.

“This partnership marks a significant milestone on the path to creating a world where individuals with celiac disease can travel with confidence and enjoy enriching experiences without compromising their health,” said Marilyn G. Geller, CEO of the Celiac Disease Foundation. “By combining the expertise of the Celiac Disease Foundation with the dedication of Celiac Cruise, we are proud to set the premier standard for gluten-free travel.”

“Celiac Cruise is honored to join forces with the Celiac Disease Foundation to redefine gluten-free travel,” said Maureen Basye, founder of Celiac Cruise. “Our shared vision of fostering a supportive and enjoyable environment for the celiac community aligns perfectly with our mission. Together, we aim to create unforgettable experiences that go beyond the boundaries of dietary restrictions.”

Living with celiac disease poses unique challenges, and individuals affected by this life-changing autoimmune disease find it difficult to enjoy travel without the fear of gluten exposure. This new partnership is designed to address these concerns by creating a supportive, safe environment for those affected by celiac disease to explore the world.

Over the past three years Celiac Cruise has provided more than 4,000 individuals with the opportunity to experience adventurous, safe, gluten-free travel around the world. Today, Celiac Cruise and the Celiac Disease Foundation have formalized their partnership, which will offer an array of benefits for the celiac disease community:

Safe Travel Experiences: All cruise experiences will be tailored to meet the dietary needs of individuals with celiac disease, including dedicated gluten-free menus, strict food handling protocols, and collaboration with both Royal Caribbean and AmaWaterways to create safe, enjoyable environments.

Educational Programming and Community Support: Brace yourselves for a wave of knowledge onboard future cruises! Workshops and seminars will be offered, and support groups will be available for families of all ages. Look for many opportunities to learn about the latest developments and research in celiac disease, along with pointers on navigating the gluten-free lifestyle – all while cruising to fantastic destinations.

Philanthropic Endeavors: As part of this dedicated effort to positively impact people affected by celiac disease, a portion of proceeds from cruises and onboard events will be directed to the Celiac Disease Foundation to advance education, fund vital research, and address food insecurity. Every dollar raised brings us closer to a world where no one faces the challenges of celiac disease alone.

For more information on upcoming gluten-free cruises and educational initiatives, please visit www.celiaccruise.com and www.celiac.org.

About the Celiac Disease Foundation

The Celiac Disease Foundation, established in 1990, is a leading global patient advocacy organization committed to accelerating diagnosis, treatments, and a cure for celiac disease. Our mission is to improve the health and well-being of the millions of individuals around the world affected by this genetic autoimmune disease through our strategic investments in research, advocacy, and education. Our iCureCeliac® Patient Registry and extensive patient recruitment services at iRecruitCeliac.org enable us to identify qualified patient candidates and speed their enrollment to advance critical disease research. Our unparalleled advocacy program has led the way to secure federal recognition and first-ever research funding from agencies including the U.S. National Institutes of Health and the Department of Defense. We adhere to the highest scientific and ethical standards as we work each day to promote understanding of celiac disease, empower our patient and provider community, and collaborate with partners and stakeholders to carry our mission forward.

About Celiac Cruise

Celiac Cruise pioneers gluten-free travel, dedicated to unforgettable journeys for those with celiac disease or gluten restrictions. Beyond traditional travel, we blend adventure and community, partnering with leaders like Royal Caribbean and AmaWaterways for memory making without compromising dietary needs. We foster togetherness in the celiac community, making each cruise safe, enjoyable, and gluten-free. Explore confidently with global itineraries, combining adventure and dietary prioritization. Visit www.celiaccruise.com to learn more and embark on worry-free adventures with Celiac Cruise.

Contacts

Celiac Disease Foundation
Jennifer Roop
jennifer.roop@celiac.org
818-716-1513, extension 106

Celiac Cruise
Maureen Basye
Maureen@CeliacCruise.com
703-869-8481

Celiac Disease Foundation LogoCeliac Disease Foundation Logo

Celiac Disease Foundation


Release Versions

Contacts

Celiac Disease Foundation
Jennifer Roop
jennifer.roop@celiac.org
818-716-1513, extension 106

Celiac Cruise
Maureen Basye
Maureen@CeliacCruise.com
703-869-8481

Social Media Profiles
More News From Celiac Disease Foundation

Celiac Disease Foundation Announces Three Senior-Level Appointments as Organization Expands in 2024

LOS ANGELES--(BUSINESS WIRE)--The Celiac Disease Foundation, a global leader in celiac disease patient advocacy, is expanding its operations with the appointment of three senior-level staff. These roles are aligned with the Foundation’s latest strategic plan and ongoing work to accelerate diagnosis, treatments, and a cure for celiac disease – one of the world’s most prevalent genetic autoimmune diseases. Joining the Foundation are Robert Anderson, MB, ChB, PhD as Principal Science & Innovat...

Celiac Disease Foundation Teams Up with Mark Cuban Cost Plus Drug Company

LOS ANGELES--(BUSINESS WIRE)--The Celiac Disease Foundation, a global leader in celiac disease patient advocacy, today announces its new relationship with Mark Cuban Cost Plus Drug Company (Cost Plus Drugs) to provide resources for celiac disease patients and all consumers concerned about potential gluten in the company’s medications. Currently, there is no medication, treatment, or cure for celiac disease, nor is there an effective method for prevention. The only course of action to avoid inte...

Celiac Disease Foundation Debuts Innovative iRecruitCeliac Patient Recruitment Platform

LOS ANGELES--(BUSINESS WIRE)--The Celiac Disease Foundation, a trusted partner in optimizing patient recruitment and retention, today announces the launch of its iRecruitCeliac platform, which brings together solutions to accelerate enrollment in clinical trials for celiac disease and comorbid conditions. With an established, 30-year track record of patient engagement, the Foundation understands that patient recruitment and retention pose significant challenges in bringing new drugs to market....
Back to Newsroom